Patient specific proteolytic activity of monocyte-derived macrophages and osteoclasts predicted with temporal kinase activation states during differentiation

Cathepsin S Cannibalism of Cathepsin K as a Mechanism to Reduce Type I Collagen Degradation

(2012) Zachary T. Barry et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Tumor necrosis factor alpha stimulates cathepsin K and V activity via juxtacrine monocyte–endothelial cell signaling and JNK activation

(2012) Philip M. Keegan et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Manipulating substrate and pH in zymography protocols selectively distinguishes cathepsins K, L, S, and V activity in cells and tissues

(2011) Catera L. Wilder et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Association Between Serum Cathepsin S and Mortality in Older Adults

(2011) Elisabeth Jobs et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Serum Cathepsin K levels are not suitable to differentiate women with chronic bone disorders such as osteopenia and osteoporosis from healthy pre- and postmenopausal women

(2011) Daniela Adolf et al.   MATURITAS

Detection of femtomole quantities of mature cathepsin K with zymography

(2010) Weiwei A. Li et al.   ANALYTICAL BIOCHEMISTRY

Conformational flexibility and allosteric regulation of cathepsin K

(2010) Marko Novinec et al.   BIOCHEMICAL JOURNAL

IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion

(2010) V. Gocheva et al.   GENES & DEVELOPMENT

Pharmacological inhibitors to identify roles of cathepsin K in cell-based studies: a comparison of available tools

(2009) Sylvie Desmarais et al.   BIOLOGICAL CHEMISTRY

Cathepsin K inhibitors for osteoporosis and potential off-target effects

(2009) Dieter Brömme et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Serum cathepsin K and cystatin C concentration in patients with advanced non-small-cell lung cancer during chemotherapy.

(2009) Wojciech Naumnik et al.   FOLIA HISTOCHEMICA ET CYTOBIOLOGICA

Serum cathepsin K as a marker of bone metabolism in postmenopausal women treated with alendronate

(2009) Manuel Muñoz-Torres et al.   MATURITAS

Multipathway Kinase Signatures of Multipotent Stromal Cells Are Predictive for Osteogenic Differentiation

(2009) Manu O. Platt et al.   STEM CELLS

Cathepsin K inhibitors as treatment of bone metastasis

(2009) Céline Le Gall et al.   Current Opinion in Supportive and Palliative Care

Usefulness of Serum Cathepsin L as an Independent Biomarker in Patients With Coronary Heart Disease

(2008) Yingxian Liu et al.   AMERICAN JOURNAL OF CARDIOLOGY

Novel vitamin D3 analogs, 1α, 25(OH)2D3-26, 23-lactam (DLAMs), antagonize bone resorption via suppressing RANKL expression in osteoblasts

(2008) Masaki Inada et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The Crystal and Molecular Structures of a Cathepsin K:Chondroitin Sulfate Complex

(2008) Zhenqiang Li et al.   JOURNAL OF MOLECULAR BIOLOGY

Calcification of the internal elastic lamina of coronary arteries

(2008) Robert G Micheletti et al.   MODERN PATHOLOGY

An Enhancer 20 Kilobases Upstream of the Human Receptor Activator of Nuclear Factor-κB Ligand Gene Mediates Dominant Activation by 1,25-Dihydroxyvitamin D3

(2008) Robert D. Nerenz et al.   MOLECULAR ENDOCRINOLOGY

High Cathepsin K Levels in Men with Differentiated Thyroid Cancer on Suppressive l-Thyroxine Therapy

(2008) Peter Mikosch et al.   THYROID

Cysteine cathepsins: Cellular roadmap to different functions

(2007) Klaudia Brix et al.   BIOCHIMIE

Circulating cathepsin K and cystatin C in patients with cancer related bone disease: Clinical and therapeutic implications

(2007) Francesca M. Tumminello et al.   BIOMEDICINE & PHARMACOTHERAPY